Medium impact
Vocal Cord Paralysis / Insufficiency Treatments (CPB 0253, reviewed 2026-04-15)
Aetna·Effective Apr 15, 2026
HCPCS L8607 is officially defined as "Injectable bulking agent for vocal cord medialization, 0.1 ml, includes shipping and necessary supplies." HCPCS L8607 is referenced in 1 tracked payer policy change from Aetna. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for HCPCS L8607 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.
Related
Get alerts for changes like this
Save a search and receive a daily digest whenever a new policy change matches your filters.